Drägerwerk stock holds strong as year-to-date gains stay high
Published on 08/20/2026 at 17:09 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Drägerwerk AG & Co. KGaA (DE0005550636) stock is trading close to recent highs as of August 19, 2026, with investors watching solid year-to-date gains supported by the company’s latest reported results.
Share performance and current market context
According to a recent market overview for Drägerwerk, the shares closed at 110.60 EUR on August 19, 2026 on the Tradegate venue, with a daily gain of 0.73% and a year-to-date increase of 58.67% in 2026. The MarketScreener quote snapshot for Drägerwerk AG & Co. KGaA shows the recent price and performance data for the stock.
The same Tradegate data set indicates that despite the strong year-to-date performance, the stock is modestly below levels earlier in the year, with a 1.79% decline from a reference point used in the overview for 2026 performance. MarketScreener performance data for Drägerwerk AG & Co. KGaA highlight these changes and place the shares in the broader context of the German market.
Recent fundamentals and latest reporting period
Drägerwerk’s official investor relations section on its website provides detailed historical trading data for the shares. For example, the internal share statistics table shows that on August 11, 2026, the stock traded at 111.72 EUR with a recorded trading volume of 2,523 shares, while on August 12, 2026 the price was 111.68 EUR on a volume of 492 shares. The Drägerwerk investor relations share statistics table lists these daily figures and offers a broader view of recent trading activity.
These trading data points underline the relatively tight trading range for Drägerwerk shares during August 2026, with prices between 110 EUR and 112 EUR over several sessions and modest daily volumes. The Drägerwerk IR overview of historical share prices shows that the company’s stock has maintained this range while delivering strong cumulative performance in 2026.
While the current search results focus on market data rather than a full earnings breakdown, the company’s most recent reporting period remains the key driver for the strong year-to-date performance. Based on the available overview, investors are drawing a connection between the sizable gains of 58.67% in 2026 and Drägerwerk’s operating progress in its medical technology and safety segments, even though detailed quarterly figures are not summarized in the current market excerpts. The MarketScreener overview of Drägerwerk share performance in 2026 presents the year-to-date percentage change as one of the main signals for investor sentiment.
Sector backdrop and index environment
Drägerwerk trades in the context of the German equity market, where the DAX index recently fell 0.3% to below 26,000 points on August 20, 2026, marking the fourth consecutive session of losses and the lowest level since late July. A Trading Economics report on DAX performance on August 20, 2026 notes the index decline and signals a cautious tone in the broader market.
Against that backdrop, the solid year-to-date advance of 58.67% for Drägerwerk shares in 2026 stands out relative to the more muted index moves. The MarketScreener comparison of Drägerwerk year-to-date performance with broader market context indirectly highlights the contrast between the company’s strong stock gains and the DAX’s recent pullback.
For investors, this divergence underlines how stock-specific drivers such as earnings quality, balance sheet strength, and sector positioning can outweigh short-term index fluctuations. The current data suggest that Drägerwerk’s story has resonated with the market throughout 2026, even as headline indices temporarily lose ground.
Representative product in medical technology
Drägerwerk is widely known for its medical technology offerings in hospitals, intensive care units, and emergency medicine. A representative product line from the company’s portfolio is its advanced ventilator systems for critical care, which are designed to support patients with respiratory failure in intensive care settings. These devices typically provide highly configurable ventilation modes, built-in monitoring functions, and integration with hospital information systems, helping clinicians tailor therapy and track key parameters over time.
By focusing on ventilator technology, Drägerwerk positions itself as a key partner for hospitals in managing complex respiratory cases. The company’s systems aim to combine precision in air and oxygen delivery with safety features that protect patients against pressure-related complications. Over recent years, such equipment has also been central in responses to respiratory disease outbreaks, increasing awareness of the importance of reliable ventilator capacity in modern healthcare systems.
Closing view on Drägerwerk stock
As of the Tradegate close on August 19, 2026, Drägerwerk stock was quoted at 110.60 EUR, reflecting a daily increase of 0.73% and a year-to-date gain of 58.67% in 2026 that signals strong investor confidence in the company’s trajectory.
Fact box
Company: Drägerwerk AG & Co. KGaA
ISIN: DE0005550636
Ticker: not specified
Exchange: Tradegate and German home markets
Price (as of August 19, 2026, 4:02 p.m. ET): 110.60 EUR
Sector / Industry: Medical technology and safety equipment
Index membership: German equity indices
